Operating Company Healthcare

ToxStrategies

Katy, Texas, United States

ToxStrategies is a multidisciplinary scientific consulting firm that develops innovative solutions to address scientific, technical, and regulatory challenges for clients. It provides consulting by health scientists, regulatory specialists, and engineers across toxicology and related regulatory/scientific work (e.g., consumer products, pharmaceuticals, medical devices, pesticides, industrial chemicals, and environmental contaminants).

Focus Areas
Toxicology, Regulatory consulting, Epidemiology

Tracked deals

3

3 tracked deals across 2023-2024.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

3 addon

ToxStrategies Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for ToxStrategies. 1 2023 2 2024

Supporting Data

Recent Transactions

  • ToxStrategies Acquires Suttons Creek
    August 13, 2024
    Buyer
    ToxStrategies, Renovus Capital Partners, Brookside Capital Partners
    Target
    Suttons Creek
    Industry
    Healthcare Services
    Location
    California, United States
    Type
    Addon

    ToxStrategies, a Renovus Capital Partners portfolio company, has acquired Suttons Creek to expand its combination-product development and regulatory consulting capabilities. Brookside Capital Partners provided financing to support the add-on acquisition; Suttons Creek will operate as a division of ToxStrategies and its founder Steven Badelt will continue to lead the business. Terms were not disclosed.

  • ToxStrategies Acquires Clintrex Research Corporation
    June 25, 2024
    Buyer
    ToxStrategies, Renovus Capital Partners
    Target
    Clintrex Research Corporation
    Industry
    Healthcare Services
    Location
    Florida, United States
    Type
    Addon

    ToxStrategies, a Renovus Capital Partners–backed scientific consulting firm based in Katy, Texas, has acquired Clintrex Research Corporation, a Sarasota-based clinical and regulatory development services provider focused on neurodegenerative and CNS therapies. The deal (terms undisclosed) expands ToxStrategies' clinical, regulatory, biostatistics and drug‑development capabilities and is intended to broaden its end‑market reach in the life sciences sector.

  • ToxStrategies (Renovus-backed) Acquires Modality Solutions
    August 8, 2023
    Buyer
    ToxStrategies, Renovus Capital Partners
    Target
    Modality Solutions
    Industry
    Healthcare Services
    Location
    Texas, United States
    Type
    Addon

    ToxStrategies, a Renovus Capital Partners-backed life sciences consulting platform, has acquired Modality Solutions, a Houston-based firm specializing in biopharmaceutical cold-chain optimization and shipping validation testing. The add-on expands ToxStrategies' cold-chain, package engineering, and regulatory testing capabilities and will operate as a division of ToxStrategies with Modality's founders continuing to lead the business.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 3 tracked deals by ToxStrategies. Acquisitions in California 1 tracked deal by ToxStrategies. Acquisitions in Florida 1 tracked deal by ToxStrategies. Acquisitions in Texas 1 tracked deal by ToxStrategies.

Related articles

Selling a company? Get in front of buyers like ToxStrategies

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →